engleski

Serum platelet-activating factor acetylhydrolase activity in patients with angiographically established cerebrovascular stenosis

Serum platelet-activating factor acethylhydrolase (PAF-AH)activity was investigated in the group of 32 patients aged 49-80 years with cerebrovascular atherosclerotic changes established angiographically in accordance to the control no-stenosis group of 55 patients aged 44-76 years with normal cerebral arteries on ultrasound examination. PAF-AH activity was measured with spectrophotmetric assay (AZWELL Auto PAF-AH, Osaka, Japan) on an Olympus AU-600 analyzer. Serum PAF-AH activities did not differ significantly between patients group with stenosis and controls (median values 351 U/L vs 380 U/L, p>0.05) and show the most significant relationship with total cholesterol and LDL cholesterol concentrations in both studied groups

cerebral arteries; serum platelet-activating factor acethylhydrolase; risk factors y stenosis; risk factors

nije evidentirano